Pertuzumab
CAS 380610-27-5Biologic
Overview
Pertuzumab is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of HER2-positive metastatic breast cancer. It works by targeting and inhibiting the HER2 receptor, which is overexpressed in some breast cancer cells.
Therapeutic areas
OncologyBreast Cancer Treatment
Verified Supplier Partner
Do you supply Pertuzumab? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.